May/June 2016

Well-Being: The Holy Grail of Health Care

Allen C. Ho, MD, and Robert L. Avery, MD

News

Medical Update

Advances in Therapy for Dry AMD

Numerous approaches to treatment of dry AMD are under development.

Aron Shapiro

The Jump From Fellow to Attending

The surgical training is finished. Now comes the hard part.

Jayanth Sridhar, MD

An Analysis of CMS Retina Utilization Statistics

Recent changes in reimbursement will likely lead to changes in utilization.

Riva Lee Asbell

Vitrectomy With ILM Removal for DME Resistant to Conventional Treatment

Although this procedure can be effective, it should be avoided in eyes with certain characteristics.

Sergio Rojas, MD, and Ezequiel Diaz Benitez, MD

Anemic Retinopathy: Case Reports and Disease Features

Clinical findings vary depending on the etiology of the anemia.

Gaurav Y. Shah, MD, and Rohit Modi, MD

Tattoo-Associated Uveitis

What to look for and how to manage this rare condition.

Tahreem A. Mir, MD; Marguerite O. Linz; and Ashvini K. Reddy, MD

ICGA of Vortex Vein Varix Simulating Choroidal Melanoma

VVV is typically asymptomatic and benign, but can simulate a life-threatening condition. Know how to tell the difference.

Michael J. Reynolds, BS; Kareem Sioufi, MD; and Carol L. Shields, MD

Managing Severe Open Globe Injuries Through the Years

A brief history: Part 1.

Dante J. Pieramici, MD

Posttraumatic Lens Expulsion With Suprachoroidal Hemorrhage

In this trauma case, temporarily leaving perfluorocarbon liquid in the eye prevented unwanted complications.

Manish Nagpal, MS, DO, FRCS(Edin)

The New Eyetube

William F. Wiley, MD

Don't Take “Yes” for an Answer

Gain cooperation from your staff by encouraging them to ask questions and express their concerns.

Michelle Beckman, JD

The Pachychoroid Clinical Spectrum

A new risk and disease modifier in macular disorders.

Rosa Dolz-Marco, MD, PhD; Kunal K. Dansingani, MA, FRCOphth; and K. Bailey Freund, MD

Vitreous: The Next Frontier

Vitreous liquefaction is the cause of many age-related ocular diseases. Figuring out its cause—and how to prevent it—could help to preserve eye health.

Nancy M. Holekamp, MD

Polypoidal Choroidal Vasculopathy

It is crucial to distinguish this entity from neovascular AMD; treatment burden can be reduced if appropriate therapy is applied.

Jessica G. Shantha, MD, and Gregg T. Kokame, MD, MMM

Extended-Duration Therapeutics for Treatment of Wet AMD

Promising treatment options under investigation may someday lead to more successful disease management.

Liliya Golas, MD, and Jeffrey L. Olson, MD

A Novel Compound for Treatment of Wet AMD

Clinical studies are evaluating a new anti-VEGF agent's potential to join current treatment options.

Saradha Chexal, MD; Ivana Gunderson, BS; Brian S. Berger, MD; and Chirag Jhaveri, MD

Home Monitoring of Dry AMD Patients

A device used by patients helps detect early signs of CNV so treatment can be started early.

Michael J. Elman, MD

5Q With Adrienne Scott, MD

Adrienne Scott, MD, is an Assistant Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, in Baltimore, Md.

An Update on Intravitreal Sirolimus

Thomas Albini, MD, and Eric Suhler, MD, MPH